Last reviewed · How we verify
NCT05571774
Construction of a Database for TTP
trial testing collection data in TTP - Thrombotic Thrombocytopenic Purpura in 500 participants. Currently enrolling.
20 October 2027
Quick facts
| Lead sponsor | The First Affiliated Hospital of Soochow University |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 500 |
| Start date | 20 October 2022 |
| Primary completion | 20 October 2027 |
| Estimated completion | 20 October 2028 |
| Sites | 1 location across China |
Drugs / interventions tested
- collection data
Conditions studied
- TTP - Thrombotic Thrombocytopenic Purpura — all drugs for TTP - Thrombotic Thrombocytopenic Purpura →
Sponsor
The First Affiliated Hospital of Soochow University
Who can join
Eligibility, any sex, with TTP - Thrombotic Thrombocytopenic Purpura. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Information about patients was collected by reviewing the Hitech case system and telephone and outpatient follow-up, and the case database was constructed by Epidata software. The sample size is expected to be 200 cases, the participating hospital is the First Affiliated Hospital of Soochow University, and the study time frame is from Oct 20, 2022, to Oct 20, 2027. The observation indexes of the study include the basic information of patients' age and gender and the clinical related data of thrombotic thrombocytopenic purpura.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05571774
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of collection data
Trials testing the same drug.
- NCT05634928 — Construction of a Database for TMA · recruiting
Other recruiting trials for TTP - Thrombotic Thrombocytopenic Purpura
Currently open trials in the same condition.
- NCT06376786 — Italian iTTP Registry · recruiting
- NCT05950750 — Turkey Thrombotic Thrombocytopenic Purpura Disease Registry: National Multicenter Study · recruiting
Other The First Affiliated Hospital of Soochow University trials
Trials by the same sponsor.
- NCT07350863 — U69-CART-Cells For R/R T-ALL · Phase 1 · recruiting
- NCT06985498 — Immunotherapy Combined With Auto-HSCT and CD22/CD19 CAR-T Sandwich Strategy for B-ALL · Phase 2 · not yet recruiting
- NCT07463651 — MRD-guided Maintenance Post-HCT: Gilteritini vs Sorafenib · Phase 3 · recruiting
- NCT07500753 — A Single-arm, Prospective Study of a Clad-LABU Conditioning Regimen in HSCT for R/R MDS/AML in Elderly Patients · NA · recruiting
- NCT07511426 — U96-CAR-T-Cells For R/R B-ALL · Phase 1 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05571774 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by The First Affiliated Hospital of Soochow University
- Last refreshed: 7 October 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05571774.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing